[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 1974 | 0 | 1 | 1 | 0 | 0 | |||||||||||||
| 1975 | 0 | 2 | 3 | 0 | 0 | |||||||||||||
| 1976 | 0 | 1 | 4 | 0 | 0 | |||||||||||||
| 1977 | 0 | 1 | 5 | 0 | 0 | |||||||||||||
| 1978 | 0 | 3 | 8 | 0 | 0 | |||||||||||||
| 1979 | 0 | 2 | 10 | 0 | 0 | |||||||||||||
| 1980 | 0 | 3 | 13 | 0 | 0 | |||||||||||||
| 1981 | 0 | 5 | 18 | 0 | 0 | |||||||||||||
| 1982 | 0 | 2 | 20 | 0 | 0 | |||||||||||||
| 1983 | 0 | 1 | 21 | 0 | 0 | |||||||||||||
| 1985 | 0 | 1 | 22 | 0 | 0 | |||||||||||||
| 1988 | 0 | 2 | 24 | 0 | 0 | |||||||||||||
| 1989 | 0 | 1 | 25 | 0 | 0 | |||||||||||||
| 1990 | 0 | 0.15 | 0 | 0 | 3 | 28 | 0 | 0 | 3 | 4 | 0 | 0 | 0.08 | |||||
| 1991 | 0 | 0.14 | 0 | 0 | 2 | 30 | 0 | 0 | 4 | 6 | 0 | 0 | 0.08 | |||||
| 1992 | 0.2 | 0.12 | 0.03 | 0.13 | 1 | 31 | 0 | 1 | 1 | 5 | 1 | 8 | 1 | 0 | 0 | 0.08 | ||
| 1993 | 0 | 0.16 | 0.03 | 0 | 1 | 32 | 0 | 1 | 2 | 3 | 9 | 0 | 0 | 0.1 | ||||
| 1994 | 0 | 0.16 | 0 | 0 | 2 | 34 | 0 | 2 | 2 | 8 | 0 | 0 | 0.08 | |||||
| 1995 | 0 | 0.21 | 0 | 0 | 1 | 35 | 7 | 2 | 3 | 9 | 0 | 0 | 0.11 | |||||
| 1997 | 0 | 0.27 | 0 | 0 | 3 | 38 | 3 | 3 | 1 | 5 | 0 | 0 | 0.15 | |||||
| 1998 | 0.67 | 0.3 | 0.22 | 0.43 | 3 | 41 | 5 | 9 | 12 | 3 | 2 | 7 | 3 | 1 | 11.1 | 6 | 2 | 0.18 |
| 2003 | 0 | 0.51 | 0 | 0 | 1 | 42 | 0 | 16 | 0 | 3 | 0 | 0 | 0.29 | |||||
| 2004 | 1 | 0.57 | 0.05 | 1 | 1 | 43 | 1 | 2 | 18 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0.35 | |
| 2006 | 0 | 0.58 | 0.02 | 0 | 2 | 45 | 0 | 1 | 21 | 1 | 2 | 0 | 0 | 0.34 | ||||
| 2007 | 0 | 0.5 | 0.04 | 0 | 1 | 46 | 0 | 2 | 23 | 2 | 4 | 0 | 0 | 0.29 | ||||
| 2008 | 0 | 0.58 | 0.02 | 0.2 | 5 | 51 | 18 | 1 | 24 | 3 | 5 | 1 | 0 | 0 | 0.3 | |||
| 2009 | 0.17 | 0.56 | 0.05 | 0.11 | 6 | 57 | 36 | 3 | 27 | 6 | 1 | 9 | 1 | 2 | 66.7 | 2 | 0.33 | 0.32 |
| 2012 | 0 | 0.65 | 0.09 | 0.33 | 1 | 58 | 0 | 5 | 45 | 0 | 12 | 4 | 0 | 0 | 0.34 | |||
| 2014 | 0 | 0.65 | 0.17 | 0.43 | 1 | 59 | 1 | 10 | 66 | 1 | 7 | 3 | 1 | 10 | 1 | 1 | 0.34 | |
| 2015 | 0 | 0.63 | 0.07 | 0 | 1 | 60 | 0 | 4 | 70 | 1 | 2 | 0 | 0 | 0.35 | ||||
| 2016 | 0.5 | 0.63 | 0.05 | 0.33 | 2 | 62 | 0 | 3 | 73 | 2 | 1 | 3 | 1 | 0 | 0 | 0.34 | ||
| 2017 | 0 | 0.62 | 0.1 | 0 | 7 | 69 | 6 | 7 | 80 | 3 | 5 | 3 | 42.9 | 4 | 0.57 | 0.34 | ||
| 2018 | 0 | 0.62 | 0.06 | 0 | 3 | 72 | 4 | 4 | 84 | 9 | 11 | 1 | 25 | 0 | 0.35 | |||
| 2019 | 0 | 0.62 | 0.01 | 0 | 4 | 76 | 3 | 1 | 85 | 10 | 14 | 0 | 0 | 0.37 | ||||
| 2020 | 0.29 | 0.7 | 0.05 | 0.12 | 2 | 78 | 0 | 4 | 89 | 7 | 2 | 17 | 2 | 0 | 0 | 0.72 | ||
| 2021 | 0.5 | 1.01 | 0.11 | 0.39 | 3 | 81 | 0 | 9 | 98 | 6 | 3 | 18 | 7 | 0 | 0 | 0.42 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2009 | Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?. (2009). Johannesson, Magnus ; Zethraeus, N ; Kobelt, G ; Jonsson, L. In: Briefings. RePEc:ohe:briefg:000228. Full description at Econpapers || Download paper | 12 |
| 2 | 2009 | Deliberative Processes in Decisions about Health Care Technologies. (2009). Culyer, Anthony. In: Briefings. RePEc:ohe:briefg:000231. Full description at Econpapers || Download paper | 11 |
| 3 | 2009 | Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries. (2009). Garau, Martina ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000227. Full description at Econpapers || Download paper | 8 |
| 4 | 1995 | Handling Uncertainty in the Results of Economic Evaluation. (1995). Briggs, A. In: Briefings. RePEc:ohe:briefg:000410. Full description at Econpapers || Download paper | 8 |
| 5 | 2008 | The Market for Biosimilars: Evolution and Policy Options. (2008). Towse, Adrian ; Mestre-Ferrandiz, J ; Chauhan, D. In: Briefings. RePEc:ohe:briefg:000238. Full description at Econpapers || Download paper | 8 |
| 6 | 2008 | New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?. (2008). Rutten, F ; Drummond, M F. In: Briefings. RePEc:ohe:briefg:000237. Full description at Econpapers || Download paper | 8 |
| 7 | 1998 | Trends in Economic Evaluation. (1998). Pritchard, C. In: Briefings. RePEc:ohe:briefg:000444. Full description at Econpapers || Download paper | 6 |
| 8 | 2009 | American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis. (2009). Neumann, P J. In: Briefings. RePEc:ohe:briefg:000232. Full description at Econpapers || Download paper | 4 |
| 9 | 2017 | Additional Elements of Value for Health Technology Assessment Decisions. (2017). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Fischer, A ; Masterson, R ; Mestre-Ferrandiz, J ; Henshall, C ; West, P. In: Briefings. RePEc:ohe:briefg:001851. Full description at Econpapers || Download paper | 3 |
| 10 | 2009 | How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England. (2009). Sussex, J. In: Briefings. RePEc:ohe:briefg:000230. Full description at Econpapers || Download paper | 3 |
| 11 | 2018 | Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. (2018). Neri, Margherita ; Garau, Martina ; Towse, A. In: Briefings. RePEc:ohe:briefg:002084. Full description at Econpapers || Download paper | 3 |
| 12 | 1998 | From Efficacy to Cost-Effectiveness. (1998). Towse, Adrian ; Drummond, M F. In: Briefings. RePEc:ohe:briefg:000438. Full description at Econpapers || Download paper | 3 |
| 13 | 2019 | 2018 OHE Annual Report to the Charity Commission. (2019). Of, Office. In: Briefings. RePEc:ohe:briefg:002218. Full description at Econpapers || Download paper | 2 |
| 14 | 1975 | Infant and Child Health. (1975). Of, Office . In: Briefings. RePEc:ohe:briefg:000253. Full description at Econpapers || Download paper | 2 |
| 15 | 1997 | The Pros and Cons of Modelling in Economic Evaluation. (1997). Of, Office . In: Briefings. RePEc:ohe:briefg:000428. Full description at Econpapers || Download paper | 2 |
| 16 | 2004 | Developments in Economic Evaluation in Health Care: A Review of HEED. (2004). Pritchard, C. In: Briefings. RePEc:ohe:briefg:000492. Full description at Econpapers || Download paper | 2 |
| 17 | 2014 | What is the Role of HTA for Biosimilars?. (2014). Towse, Adrian ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000075. Full description at Econpapers || Download paper | 2 |
| 18 | 1997 | Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry. (1997). Towse, Adrian ; Cave, M. In: Briefings. RePEc:ohe:briefg:000427. Full description at Econpapers || Download paper | 2 |
| 19 | 2008 | Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective. (2008). Garrison, L ; Cross, J T. In: Briefings. RePEc:ohe:briefg:000239. Full description at Econpapers || Download paper | 2 |
| 20 | 2017 | Incentives for New Drugs to Tackle Anti-Microbial Resistance. (2017). Towse, Adrian ; Mestre-Ferrandiz, J ; Ferraro, J. In: Briefings. RePEc:ohe:briefg:001842. Full description at Econpapers || Download paper | 2 |
| 21 | 1993 | The Impact of Unemployment on Health. (1993). Griffin, J. In: Briefings. RePEc:ohe:briefg:000401. Full description at Econpapers || Download paper | 1 |
| 22 | 2017 | Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C. In: Briefings. RePEc:ohe:briefg:001835. Full description at Econpapers || Download paper | 1 |
| 23 | 2018 | Private Provision of Publicly Funded Health Care: The Economics of Ownership. (2018). Chalkley, Martin ; Sussex, J. In: Briefings. RePEc:ohe:briefg:002055. Full description at Econpapers || Download paper | 1 |
| 24 | 1991 | Factors Influencing Clinical Decisions in General Practice. (1991). Of, Office . In: Briefings. RePEc:ohe:briefg:000385. Full description at Econpapers || Download paper | 1 |
| 25 | 2019 | Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?. (2019). Zamora, B ; Towse, A ; Cole, A. In: Briefings. RePEc:ohe:briefg:002165. Full description at Econpapers || Download paper | 1 |
| 26 | 2008 | Health Care Services and the Single European Market. (2008). Mountford, L ; Dawson, D. In: Briefings. RePEc:ohe:briefg:000240. Full description at Econpapers || Download paper | 1 |
| 27 | 1982 | Ill in Europe. (1982). Vaizey, J. In: Briefings. RePEc:ohe:briefg:000329. Full description at Econpapers || Download paper | 1 |
| 28 | 2003 | Reducing Harm to Patients in the National Health Service. Will the Governments Compensation Proposals Help?. (2003). Towse, Adrian ; Gray, Alastair ; Salinas, R ; Rickman, N ; Fenn, P. In: Briefings. RePEc:ohe:briefg:000484. Full description at Econpapers || Download paper | 1 |
| 29 | 2019 | How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy. (2019). Sampson, Christopher ; Garau, M. In: Briefings. RePEc:ohe:briefg:002146. Full description at Econpapers || Download paper | 1 |
| 30 | 1980 | Effects of Prescription Charges. (1980). Of, Office . In: Briefings. RePEc:ohe:briefg:000310. Full description at Econpapers || Download paper | 1 |
| 31 | 1994 | The Impact of Behavioural and Biomedical Advance on Health Trends over the Next 25 Years. (1994). Hall, M. In: Briefings. RePEc:ohe:briefg:000407. Full description at Econpapers || Download paper | 1 |
| 32 | 2017 | Transferability of HTA. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C ; Barnsley, P. In: Briefings. RePEc:ohe:briefg:001837. Full description at Econpapers || Download paper | 1 |
| 33 | 2020 | 2019 OHE Annual Report to the Charity Commission. (2020). Of, Office. In: Briefings. RePEc:ohe:briefg:002315. Full description at Econpapers || Download paper | 1 |
| 34 | 1979 | Immunisation for Everyone ââ¬â The Polio Experience. (1979). Of, Office . In: Briefings. RePEc:ohe:briefg:000300. Full description at Econpapers || Download paper | 1 |
| 35 | 2018 | OHE Annual Report to the Charity Commission for the Year 2017. (2018). Of, The Office. In: Briefings. RePEc:ohe:briefg:002079. Full description at Econpapers || Download paper | 1 |
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2019 | 2018 OHE Annual Report to the Charity Commission. (2019). Of, Office. In: Briefings. RePEc:ohe:briefg:002218. Full description at Econpapers || Download paper | 2 |
| Year | Title | |
|---|---|---|
| 2021 | The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment. (2021). Whittal, Amanda ; Nicod, Elena ; Meregaglia, Michela. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:5:d:10.1007_s40271-020-00493-w. Full description at Econpapers || Download paper | |
| 2021 | Payment Models for Multi-Indication Therapies. (2021). Neri, Margherita ; Cookson, G ; Cole, A. In: Consulting Reports. RePEc:ohe:conrep:002380. Full description at Econpapers || Download paper | |
| 2021 | An empirical ship domain based on evasive maneuver and perceived collision risk. (2021). Valdez, Osiris A ; Du, Lei ; Zhang, Weibin ; Kujala, Pentti ; Goerlandt, Floris ; Huang, Yamin. In: Reliability Engineering and System Safety. RePEc:eee:reensy:v:213:y:2021:i:c:s0951832021002829. Full description at Econpapers || Download paper |
| Year | Citing document |
|---|
| Year | Citing document |
|---|